Literature DB >> 1634662

Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators.

J B Cavender1, W J Rogers, L D Fisher, B J Gersh, C J Coggin, W O Myers.   

Abstract

OBJECTIVES: The goal of this study was to ascertain how continued cigarette smoking or smoking cessation related to long-term survival and morbidity in patients with established coronary artery disease managed with medical therapy or coronary bypass surgery.
BACKGROUND: Although the association of cigarette smoking with coronary artery disease is well established, the morbidity and mortality associated with smoking behavior in patients with such disease receiving medical or surgical therapy are less well established.
METHODS: The 780 patients randomized to medical therapy or coronary bypass surgery in the Coronary Artery Surgery Study (CASS) were subgrouped according to smoking behavior during a mean 11.2-year follow-up interval. Comparisons between smokers and nonsmokers were accomplished by univariate and Cox time-dependent multivariate analyses.
RESULTS: Survival at 10 years after entry into the study was 82% among 468 patients who reported no smoking during follow-up (nonsmokers) compared with 77% among the 312 smokers (p = 0.025). Survival was 80% among those who smoked at entry but stopped (quitters) versus 69% among those who continued smoking (p = 0.025). For patients who smoked at baseline and were randomized to bypass surgery, survival at 10 years was 84% among quitters and 68% among nonquitters (p = 0.018); the difference in survival between quitters (75%) and nonquitters (71%) was less among those randomized to medical therapy (p = NS). Among those who smoked at baseline, continued smoking increased the relative risk of death by 1.73. After 10 years, smokers, in comparison with nonsmokers, were less likely to be angina free and more likely to be unemployed and had more activity limitation and more hospital admissions (primarily for chest pain, heart attack, cardiac catheterization, peripheral vascular surgery and stroke).
CONCLUSIONS: Thus, among patients with documented coronary artery disease, continued cigarette smoking may result in decreased survival--especially among those undergoing bypass surgery. Moreover, smokers have more angina, more unemployment, a greater limitation of physical activity and more hospital admissions.

Entities:  

Mesh:

Year:  1992        PMID: 1634662     DOI: 10.1016/0735-1097(92)90092-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  17 in total

1.  Ten year audit of secondary prevention in coronary bypass patients.

Authors:  R J Irving; S H Oram; J Boyd; P Rutledge; F McRae; P Bloomfield
Journal:  BMJ       Date:  2000-07-01

2.  Coronary artery bypass surgery in smokers.

Authors:  E Shelley
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

3.  Non-culprit coronary lesions in young patients have higher rates of atherosclerotic progression.

Authors:  Jiantao Li; Yunfeng Han; Jing Jing; Shengxian Tu; Weiren Chen; Johan H C Reiber; Yundai Chen
Journal:  Int J Cardiovasc Imaging       Date:  2015-03-10       Impact factor: 2.357

4.  Smoking and coronary artery bypass surgery.

Authors:  D G Julian
Journal:  Br Heart J       Date:  1994-07

5.  A semiparametrically efficient estimator of the time-varying effects for survival data with time-dependent treatment.

Authors:  Huazhen Lin; Zhe Fei; Yi Li
Journal:  Scand Stat Theory Appl       Date:  2015-11-09       Impact factor: 1.396

6.  Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: randomised controlled trial.

Authors:  Peter Hajek; Tamara Z Taylor; Peter Mills
Journal:  BMJ       Date:  2002-01-12

Review 7.  The benefits of stopping smoking and the role of nicotine replacement therapy in older patients.

Authors:  S G Gourlay; N L Benowitz
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

8.  Changing health behaviors to improve health outcomes after angioplasty: a randomized trial of net present value versus future value risk communication.

Authors:  M E Charlson; J C Peterson; C Boutin-Foster; W M Briggs; G G Ogedegbe; C E McCulloch; J Hollenberg; C Wong; J P Allegrante
Journal:  Health Educ Res       Date:  2007-11-19

9.  Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results.

Authors:  Renato D Lopes; Judson B Williams; Rajendra H Mehta; Eric M Reyes; Gail E Hafley; Keith B Allen; Michael J Mack; Eric D Peterson; Robert A Harrington; C Michael Gibson; Robert M Califf; Nicholas T Kouchoukos; T Bruce Ferguson; Todd J Lorenz; John H Alexander
Journal:  Am Heart J       Date:  2012-09       Impact factor: 4.749

10.  Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry.

Authors:  Rajendra H Mehta; Deepak L Bhatt; Ph Gabriel Steg; Shinya Goto; Alan T Hirsch; Chiau-Suong Liau; Joachim Röther; Peter W F Wilson; Alain-Jean Richard; Kim A Eagle; E Magnus Ohman
Journal:  Eur Heart J       Date:  2008-11-07       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.